If damaged cells are replaceable, type 1 diabetics wouldn’t need insulin shots
Signaling a potential new approach to treating diabetes, researchers at Washington University School of Medicine in St. Louis and Harvard University have produced insulin-secreting cells from stem cells derived from patients with type 1 diabetes.
People with this form of diabetes can’t make their own insulin and require regular insulin injections to control their blood sugar. The new discovery suggests a personalized treatment approach to diabetes may be on the horizon — one that relies on the patients’ own stem cells to manufacture new cells that make insulin.
The researchers showed that the new cells could produce insulin when they encountered sugar. The scientists tested the cells in culture and in mice, and in both cases found that the cells secreted insulin in response to glucose.
The research is published May 10 in the journal Nature Communications.
“In theory, if we could replace the damaged cells in these individuals with new pancreatic beta cells — whose primary function is to store and release insulin to control blood glucose — patients with type 1 diabetes wouldn’t need insulin shots anymore,” said first author Jeffrey R. Millman, PhD, an assistant professor of medicine and of biomedical engineering at Washington University School of Medicine. “The cells we’ve manufactured sense the presence of glucose and secrete insulin in response. And beta cells do a much better job controlling blood sugar than diabetic patients can.”
Millman, whose laboratory is in the Division of Endocrinology, Metabolism and Lipid Research, began his research while working in the laboratory of Douglas A. Melton, PhD, Howard Hughes Medical Institute investigator and a co-director of Harvard’s Stem Cell Institute. There, Millman had used similar techniques to make beta cells from stem cells derived from people who did not have diabetes. In these new experiments, the beta cells came from tissue taken from the skin of diabetes patients.
“There had been questions about whether we could make these cells from people with type 1 diabetes,” Millman explained. “Some scientists thought that because the tissue would be coming from diabetes patients, there might be defects to prevent us from helping the stem cells differentiate into beta cells. It turns out that’s not the case.”
Millman said more research is needed to make sure that the beta cells made from patient-derived stem cells don’t cause tumors to develop — a problem that has surfaced in some stem cell research — but there has been no evidence of tumors in the mouse studies, even up to a year after the cells were implanted.
The Latest on: Patient-derived stem cells
via Google News
The Latest on: Patient-derived stem cells
- Man-Made Brainon June 26, 2020 at 1:06 pm
We can use patient derived stem cells and make mini brains to better understand how the disease develops and pinpoint the causes. If we have a better understanding of why the disease develops, we have ...
- Century Therapeutics Announces Acquisition of Empirica Therapeuticson June 23, 2020 at 5:05 am
Century acquired Empirica Therapeutics to leverage its iPSC-derived allogeneic cell therapies against glioblastoma (GBM).
- Scientists Discover Potential New Method for Treating Acute Myeloid Leukemiaon June 22, 2020 at 5:00 am
Scientists at the Children's Cancer Institute report they have discovered a potential new way to treat the poor-prognosis acute myeloid leukemia.
- Panel discussion: 3D cell cultures, from development to drug discoveryon June 22, 2020 at 1:17 am
BioTechniques is delighted to collate this panel of experts to discuss 3D cell cultures and their applications in ... The lab’s studies use mouse models and 3D patient-derived organoid cultures to ...
- Researchers Use Stem Cells to Create Retinal Models, Study Eye Diseaseon June 18, 2020 at 1:52 pm
“These data show that 3D retinal organoids can be used to model photoreceptor degeneration and test potential therapies to prevent photoreceptor cell death.” To develop optimal RP2 gene ...
- Higgins: $2.2 million-plus grant for University at Buffalo to support Parkinson's researchon June 15, 2020 at 9:09 am
Congressman Brian Higgins announced the award of a five-year federal grant totaling $2,224,925 through the U.S. Department of Health and Human Services to University at Buffalo for the development of ...
- Adult stem cell study shows fish oil may help with depressionon June 15, 2020 at 1:03 am
A study published in Molecular Psychiatry shows that patient-derived adult stem cells can be used to model major depressive disorder and test how a patient may respond to medication and that fish ...
- Human Stem Cell Model and CRISPR Used to Identify Degeneration in Glaucomaon June 12, 2020 at 5:00 am
Researchers at Indiana University School of Medicine have used human stem cell models to identify cells damaged by glaucoma, and have used CRISPR/Cas 9 technology to show how correcting the gene ...
- Adult stem cell study shows fish oil may help with depressionon June 11, 2020 at 12:54 pm
A study published in Molecular Psychiatry shows that patient-derived adult stem cells can be used to model major depressive disorder and test how a patient may respond to medication. Using stem ...
- Microneedling therapeutic stem cells into damaged tissueson June 10, 2020 at 6:10 pm
PRNewswire/ -- Mesenchymal stem cells (MSCs) are multipotent in that they naturally replenish the cell types that build our bone, cartilage and ...
via Bing News